Cipla announced that it has received final approval for its Abbreviated New Drug Application (ANDA) for Efavirenz Tablets 600mg from the United States Food and Drug Administration (US FDA). Cipla's Efavirenz Tablets 600mg is AB-rated generic therapeutic equivalent version of Bristol-Myers Squ...read more